Retinal vascular calibre changes after intravitreal bevacizumab or dexamethasone implant treatment for diabetic macular oedema

Wickremasinghe Sanjeewa S.; Fraser-Bell Samantha; Alessandrello Elizabeth; Mehta Hemal; Gillies Mark C.; Lim Lyndell L.

首页> 外文期刊>British journal of ophthalmology >Retinal vascular calibre changes after intravitreal bevacizumab or dexamethasone implant treatment for diabetic macular oedema

【24h】

Retinal vascular calibre changes after intravitreal bevacizumab or dexamethasone implant treatment for diabetic macular oedema

机译：玻璃体内贝伐单抗或地塞米松植入治疗后视网膜血管口径变化为糖尿病黄斑水肿

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose To compare changes in retinal vascular calibre after 2 years of treatment with intravitreal bevacizumab (BVZ) or dexamethasone implant (DEX) in patients with centre-involving diabetic macular oedema (DMO).

机译：目的在涉及糖尿病患者（DMO）的患者中，将视网膜血管口径（BVZ）或地塞米松植入（DEX）治疗两年后的视网膜血管口径的变化。

著录项

来源
《British journal of ophthalmology》 |2017年第10期|共5页
作者
Wickremasinghe Sanjeewa S.; Fraser-Bell Samantha; Alessandrello Elizabeth; Mehta Hemal; Gillies Mark C.; Lim Lyndell L.;
展开▼
作者单位

Univ Melbourne Ctr Eye Res Australia 32 Gisborne St Melbourne Vic 3002 Australia;

Univ Sydney Save Sight Inst Dept Ophthalmol Sydney NSW Australia;

Univ Melbourne Ctr Eye Res Australia 32 Gisborne St Melbourne Vic 3002 Australia;

Univ Sydney Save Sight Inst Dept Ophthalmol Sydney NSW Australia;

Univ Sydney Save Sight Inst Dept Ophthalmol Sydney NSW Australia;

Univ Melbourne Ctr Eye Res Australia 32 Gisborne St Melbourne Vic 3002 Australia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. Retinal vascular calibre changes after intravitreal bevacizumab or dexamethasone implant treatment for diabetic macular oedema [J] . Wickremasinghe Sanjeewa S., Fraser-Bell Samantha, Alessandrello Elizabeth, British journal of ophthalmology . 2017,第10期

机译：玻璃体内贝伐单抗或地塞米松植入治疗后视网膜血管口径变化为糖尿病黄斑水肿
2. Six-month changes in cytokine levels after intravitreal bevacizumab injection for diabetic macular oedema and macular oedema due to central retinal vein occlusion [J] . Wen Jing, Jiang Yanrong, Zheng Xiaoxue, British journal of ophthalmology . 2015,第10期

机译：玻璃体腔注射贝伐单抗治疗糖尿病性黄斑水肿和视网膜中央静脉阻塞引起的黄斑水肿后细胞因子水平六个月变化
3. Prospective pilot study: Efficacy of Intravitreal Dexamethasone and Bevacizumab injections in the treatment of macular Oedema associated with branch retinal vein occlusion [J] . GuignierB., Subilia-GuignierA., FournierI., Ophthalmologica: International Journal of Ophthalmology=Journal International d'Ophtalmologie . 2013,第1期

机译：前瞻性先导研究：玻璃体内地塞米松和贝伐单抗注射液治疗黄斑水肿伴视网膜分支静脉阻塞的疗效
4. Morphology of Vascular Network in Eyes with Diabetic Macular Edema Varies Based on Tolerance of Aibercept Treatment Interval Length: Preliminary Findings [C] . Prateek Prasanna, Justis Ehlers, Nathaniel Braman, Society of Photo-Optical Instrumentation Engineers;SPIE Medical Imaging Conference . 2019

机译：基于A耐受性的糖尿病性黄斑水肿眼的血管网络形态变化ibercept治疗间隔时长：初步发现
5. Arterial Thromboembolic Events following Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy for Age-Related Macular Degeneration in Regular Clinical Practice. [D] . Fafowora, Oluwatoyin Folasade. 2015

机译：在常规临床实践中，玻璃体内血管内皮生长因子抑制剂治疗与年龄相关的黄斑变性的动脉血栓栓塞事件。
6. Effect of intravitreal dexamethasone implant on retinal and choroidal thickness in refractory diabetic macular oedema after multiple anti-VEGF injections [O] . M Kim, Y J Cho, C H Lee, 2016

机译：玻璃体内地塞米松植入物对多次抗VEGF注射后难治性糖尿病性黄斑水肿的视网膜和脉络膜厚度的影响
7. PSS26 The Use of A Mixed-Treatment Comparison to Assess the Cost-Effectiveness of Ozurdex® (Dexamethasone Intravitreal Implant in Applicator) Compared With Bevacizumab Intravitreal Injections for Patients With Macular Oedema Following Branch Retinal Vein Occlusion [O] . Almond C., Hayward E., Freemantle N., 2011

机译：PSS26与贝伐珠单抗玻璃体内注射比较黄斑水肿伴分支视网膜静脉闭塞的患者相比，采用混合疗法比较来评估Ozurdex®（地塞米松玻璃体内植入剂）的成本效果

Retinal vascular calibre changes after intravitreal bevacizumab or dexamethasone implant treatment for diabetic macular oedema

摘要

著录项

相似文献

相关主题

期刊订阅